MongoDB Free cash flow increased by 25.8% to $178.47M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 626.7%, from $24.56M to $178.47M. Over 2 years (FY 2024 to FY 2026), Free cash flow shows an upward trend with a 108.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flow| Q1 '21 | Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.59M | -$21.46M | -$7.97M | $9.04M | -$47.29M | -$7.13M | $53.11M | -$25.94M | $36.34M | $51.89M | $63.07M | -$2.45M | $35.46M | $24.56M | $108.32M | $71.57M | $141.83M | $178.47M |
| QoQ Change | — | -323.8% | +62.8% | +213.3% | -623.3% | +84.9% | +845.4% | -148.8% | +240.1% | +42.8% | +21.6% | -103.9% | >999% | -30.7% | +341.1% | -33.9% | +98.2% | +25.8% |
| YoY Change | — | — | — | -5.8% | -120.3% | +10.6% | +487.7% | +45.1% | +610.1% | — | +18.8% | +90.6% | -2.4% | -52.7% | +71.7% | >999% | +300.0% | +626.7% |